BELLRING BRANDS INC
For the period ended Mar 31, 2024. Filed May 7, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 7, 2024
What changed in Management’s Discussion and Analysis?
Read the current filingPrevious report: 10-Q
Period ended 2023-12-31; filed 2024-02-06.
0001772016-24-000030
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of OperationsCurrent report: 10-Q
Period ended 2024-03-31; filed 2024-05-07.
0001772016-24-000050
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of OperationsThe baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.
Compared 73 previous paragraphs and 77 current paragraphs.
59 unchanged; 11 reworded; 5 added; 3 removed; 0 previous and 2 current paragraphs rearranged.
Tables are not compared: 2 previous and 2 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.
A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.
Added paragraphs (5)
Current report
Net sales increased $109.0 million, or 28%, during the three months ended March 31, 2024 compared to the prior year period. Sales of Premier Protein products were up $106.0 million, or 34%, driven by 45% higher volumes primarily due to increased promotional activity, which resulted in lower average net selling prices, and distribution gains. Sales of Dymatize products were up $2.8 million, or 5%, on 1% higher volumes. Average net selling prices increased in the three months ended March 31, 2024 primarily due to favorable mix. Sales ofall other products were up $0.2 million.
Current report
Operating profit increased $33.0 million, or 57%, during the three months ended March 31, 2024 compared to the prior year period. This increase was driven byhigher net sales (net of increased promotional activity), as previously discussed, and lower net product costs of $34.6 million (primarily due to lower raw material costs). These positive impacts were partially offset by higher employee-related expenses of $7.9 million and higher advertising expense of $3.3 million.
Current report
Cash used in investing activities was $0.5 million for both the six months ended March 31, 2024 and 2023 and related to capital expenditures.
Current report
Six months ended March 31, 2024
Current report
Six months ended March 31, 2023
Removed paragraphs (3)
Previous report
Cash used in investing activities for the three months ended December 31, 2023 decreased $0.1 million compared to the prior year period resulting from a decrease in capital expenditures.
Previous report
Three months ended December 31, 2023
Previous report
Three months ended December 31, 2022
Reworded paragraphs (11)
Previous wording
During fiscal 2023, input cost inflation, including raw material, packaging and manufacturing costs, impacted our supply chain and put downward pressure on profit margins. As a result, we took pricing actions on certain products in the prior fiscal year. During the first quarter of fiscal 2024, inflationary pressures on protein costs eased while other costs, such as packaging and manufacturing, have continued to face inflationary pressures. We expect this trend to continue during fiscal 2024, and inflation could have a materially adverse impact on our business in the future if inflation rates were to significantly exceed our ability to achieve price increases or cost savings or if such price increases impact demand for our products.
Current wording
During fiscal 2023, input cost inflation, including raw material, packaging and manufacturing costs, impacted our supply chain and put downward pressure on profit margins. As a result, we took pricing actions on certain products in the prior fiscal year. During the first half of fiscal 2024, inflationary pressures on protein costs eased while other costs, such as packaging and manufacturing, continued to face inflationary pressures. We expect inflationary pressures on most input costs to increase during the second half of fiscal 2024 compared to the first half of fiscal 2024, and inflation could have a materially adverse impact on our business in the future if inflation rates were to significantly exceed our ability to achieve price increases or cost savings or if such price increases impact demand for our products.
Previous wording
Net sales increased $67.7 million, or 19%, during the three months ended December 31, 2023 compared to the prior year period. Sales of Premier Protein products were up $58.2 million, or 19%, on 20% higher volumes. Volumes increased primarily due to distribution gains and incremental promotional activity. Sales of Dymatize products were up $9.6 million, or 21%, on 32% higher volumes. Volumes increased primarily due to the timing of quarterly shipments in the prior year period and distribution gains, which were partially offset by lower average net selling prices. Average net selling prices decreased in the three months ended December 31, 2023 due to increased promotional spending and unfavorable mix. Sales ofall other products were down $0.1 million.
Current wording
Net sales increased $176.7 million, or 24%, during the six months ended March 31, 2024 compared to the prior year period. Sales of Premier Protein products were up $164.2 million, or 26%, driven by 32% higher volumes primarily due to increased promotional activity, which resulted in lower average net selling prices and distribution gains. Sales of Dymatize products were up $12.4 million, or 12%, on 14% higher volumes. Volumes increased primarily due to the timing of quarterly shipments in the prior year period and distribution gains. Sales ofall other products were up $0.1 million.
Previous wording
Operating profit decreased $2.2 million, or 3%, during the three months ended December 31, 2023 compared to the prior year period. This decrease was drivenby higher accelerated amortization of $17.4 million related to the discontinuance of the PowerBar business in North America, higher employee related expenses of $5.3 million and higher professional fees of $2.6 million. These negative impacts were partially offset by higher net sales, as previously discussed, and lower net product costs of $7.4 million (driven by lower raw material and freight costs and partially offset by higher manufacturing costs).
Current wording
Operating profit increased $30.8 million, or 23%, during the six months ended March 31, 2024 compared to the prior year period. This increase was primarily drivenby higher net sales (net of increased promotional activity), as previously discussed, and lower net product costs of $42.0 million (driven by lower raw material costs, partially offset by higher manufacturing costs). These positive impacts were partially offset by higher accelerated amortization of $17.4 million related to the discontinuance of the PowerBar business in North America, higher employee-related expenses of $13.2 million and higher advertising expense of $4.3 million.
Previous wording
Interest expense, net decreased $1.8 million during the three months ended December 31, 2023 compared to the prior year period primarily due to lower borrowings outstanding under our revolving credit facility. As a result, the weighted-average interest rate on our total outstanding debt decreased to 7.0% for the three months ended December 31, 2023 from 7.1% for the three months ended December 31, 2022.
Current wording
Interest expense, net decreased $4.1 million during the six months ended March 31, 2024 compared to the prior year period primarily due to lower borrowings outstanding under our Revolving Credit Facility. As a result, the weighted-average interest rate on our total outstanding debt decreased to 7.0% for the six months ended March 31, 2024 from 7.2% for the six months ended March 31, 2023.
Previous wording
Our effective income tax rate was 24.4% for both the three months ended December 31, 2023 and 2022.
Current wording
Our effective income tax rate was 25.2% and 25.0% for the three months ended March 31, 2024 and 2023, respectively, and 24.9% and 24.7% for the six months ended March 31, 2024 and 2023, respectively.
Previous wording
During thethree months ended December 31, 2023, we repaid$25.0 million under our revolving credit facility, which is provided under our credit agreement entered into on March 10, 2022 (as amended, the “Credit Agreement”) in an aggregate principal amount of $250.0 million (the “Revolving Credit Facility”). As of December 31, 2023, there were no outstanding borrowings or letters of credit under the Revolving Credit Facility, providing us available borrowing capacity of$250.0 million. Letters of credit are available under the Revolving Credit Facility in an aggregate amount of up to $20.0 million. Our Credit Agreement provides for potential incremental revolving and term facilities at the Company’s request and at the discretion of the lenders or other persons providing such incremental facilities, in each case on terms to be determined, and also permits the Company to incur other secured or unsecured debt, in all cases subject to conditions and limitations as specified in the Credit Agreement.
Current wording
During thesix months ended March 31, 2024, we repaid$25.0 million under our revolving credit facility, which is provided under our credit agreement entered into on March 10, 2022 (as amended, the “Credit Agreement”) in an aggregate principal amount of $250.0 million (the “Revolving Credit Facility”). As of March 31, 2024, there were no outstanding borrowings or letters of credit under the Revolving Credit Facility, providing us available borrowing capacity of$250.0 million. Letters of credit are available under the Revolving Credit Facility in an aggregate amount of up to $20.0 million. Our Credit Agreement provides for potential incremental revolving and term facilities at the Company’s request and at the discretion of the lenders or other persons providing such incremental facilities, in each case on terms to be determined, and also permits the Company to incur other secured or unsecured debt, in all cases subject to conditions and limitations as specified in the Credit Agreement.
Previous wording
During the three months ended December 31, 2023, we repurchased 0.2 million shares of our common stock at an average share price of $44.27 per share and at a total cost, including accrued excise tax and broker’s commissions, of $9.4 million.
Current wording
During the six months ended March 31, 2024, we repurchased 0.6 million shares of our common stock at an average share price of $52.28 per share and at a total cost, including accrued excise tax and broker’s commissions, of $32.5 million.
Previous wording
Cash provided by operating activities for the three months ended December 31, 2023 increased $37.9 million compared to the prior year period. This increase was primarily due to moderated inventory levels in the current year period (compared to increased inventory levels in the prior year period). Additionally, interest payments decreased $1.4 million due to lower borrowings outstanding under our Revolving Credit Facility. These positive impacts were partially offset by increased tax payments (net of refunds) of $0.8 million.
Current wording
Cash provided by operating activities for the six months ended March 31, 2024 increased $70.2 million compared to the prior year period. This increase was primarily due to moderated inventory levels in the current year period (compared to increased inventory levels in the prior year period) and decreased interest payments of $3.2 million due to lower borrowings outstanding under our Revolving Credit Facility. These positive impacts were partially offset by higher receivable levels in the current year period driven by higher net sales and increased tax payments (net of refunds) of $2.1 million.
Previous wording
Cash used in financing activities for the three months ended December 31, 2023 was $37.8 million. We paid $9.4 million, including broker’s commissions, for the repurchase of shares of our common stock and repaid $25.0 million under the Revolving Credit Facility.
Current wording
Cash used in financing activities for the six months ended March 31, 2024 was $59.2 million. We paid $30.8 million, including broker’s commissions, for the repurchase of shares of our common stock and repaid $25.0 million under the Revolving Credit Facility.
Previous wording
Cash used in financing activities for the three months ended December 31, 2022 was $28.4 million. We paid $41.2 million, including broker’s commissions, for the repurchase of shares of our common stock and borrowed and repaid $55.0 million and $40.0 million, respectively, under the Revolving Credit Facility.
Current wording
Cash used in financing activities for the six months ended March 31, 2023 was $30.7 million. We paid $68.5 million, including broker’s commissions, for the repurchase of shares of our common stock and borrowed and repaid $115.0 million and $75.0 million, respectively, under the Revolving Credit Facility.
Previous wording
•risks related to the previously completed Spin-off, including our inability to take certain actions because such actions could jeopardize the tax-free status of the Spin-off and our possible responsibility for U.S. federal tax liabilities related to the Spin-off;
Current wording
•risks related to the previously completed Spin-off;
Rearranged current paragraphs (2)
Current report — wording carried from elsewhere
Interest expense, net decreased $2.3 million during the three months ended March 31, 2024 compared to the prior year period primarily due to lower borrowings outstanding under our Revolving Credit Facility (as defined in “Liquidity and Capital Resources” within this section). As a result, the weighted-average interest rate on our total outstanding debt decreased to 7.0% for the three months ended March 31, 2024 from 7.3% for the three months ended March 31, 2023.
Current report — wording carried from elsewhere
See Note 11 within “Notes to Condensed Consolidated Financial Statements” for additional information on our debt.